Skip to content
healthcare.dev

Polyethylene Glycol

NDC 68001-505, Polyethylene Glycol, powder, for suspension, from BluePoint Laboratories.

Product NDC
68001-505
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091077
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-505 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
68001-505-5568001050555238 g in 1 BOTTLE (68001-505-55)
68001-505-6968001050569510 g in 1 BOTTLE (68001-505-69)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 68001050555

    GET /v1/drugs/nadac/68001050555
  • NADAC price for package 68001050569

    GET /v1/drugs/nadac/68001050569

Use it

Look up 68001-505 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-505 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-505. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.